Other News To Note
Thursday, July 28, 2011
Trius Therapeutics Inc., of San Diego, will collaborate with Bayer Pharma AG, of Leverkusen, Germany, to develop and commercialize Trius' lead Phase III antibiotic, torezolid phosphate, in Africa, Asia (excluding North and South Korea), Latin America and the Middle East.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.